1. Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer. Chan E, Lafleur B, Rothenberg ML, Merchant N, Lockhart AC, Trivedi B, Chung CH, Coffey RJ, Berlin JD (2011) Am J Clin Oncol 34(6): 581-6
    › Primary publication · 21217396 (PubMed) · PMC3133812 (PubMed Central)
  2. A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine. Guo N, Xie J, Manning HC, Deane NG, Ansari MS, Coffey RJ, Gore J, Price RR, Baldwin RM, McIntyre JO (2011) Mol Imaging Biol 13(2): 257-64
    › Primary publication · 20532643 (PubMed) · PMC4180216 (PubMed Central)
  3. Amphiregulin exosomes increase cancer cell invasion. Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ (2011) Curr Biol 21(9): 779-86
    › Primary publication · 21514161 (PubMed) · PMC3417320 (PubMed Central)
  4. Adenoma formation following limited ablation of p120-catenin in the mouse intestine. Smalley-Freed WG, Efimov A, Short SP, Jia P, Zhao Z, Washington MK, Robine S, Coffey RJ, Reynolds AB (2011) PLoS One 6(5): e19880
    › Primary publication · 21611205 (PubMed) · PMC3096651 (PubMed Central)
  5. Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. Ayers GD, McKinley ET, Zhao P, Fritz JM, Metry RE, Deal BC, Adlerz KM, Coffey RJ, Manning HC (2010) J Ultrasound Med 29(6): 891-901
    › Primary publication · 20498463 (PubMed) · PMC2925269 (PubMed Central)
  6. Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy. Wang Y, Coffey RJ, Osheroff N, Neufeld KL (2010) PLoS One 5(4): e9994
    › Primary publication · 20368985 (PubMed) · PMC2848841 (PubMed Central)
  7. p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. Smalley-Freed WG, Efimov A, Burnett PE, Short SP, Davis MA, Gumucio DL, Washington MK, Coffey RJ, Reynolds AB (2010) J Clin Invest 120(6): 1824-35
    › Primary publication · 20484816 (PubMed) · PMC2877948 (PubMed Central)
  8. Myristoylated Naked2 antagonizes Wnt-beta-catenin activity by degrading Dishevelled-1 at the plasma membrane. Hu T, Li C, Cao Z, Van Raay TJ, Smith JG, Willert K, Solnica-Krezel L, Coffey RJ (2010) J Biol Chem 285(18): 13561-8
    › Primary publication · 20177058 (PubMed) · PMC2859517 (PubMed Central)
  9. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. Nam KT, Lee HJ, Smith JJ, Lapierre LA, Kamath VP, Chen X, Aronow BJ, Yeatman TJ, Bhartur SG, Calhoun BC, Condie B, Manley NR, Beauchamp RD, Coffey RJ, Goldenring JR (2010) J Clin Invest 120(3): 840-9
    › Primary publication · 20197623 (PubMed) · PMC2827957 (PubMed Central)
  10. Loss of Bicc1 impairs tubulomorphogenesis of cultured IMCD cells by disrupting E-cadherin-based cell-cell adhesion. Fu Y, Kim I, Lian P, Li A, Zhou L, Li C, Liang D, Coffey RJ, Ma J, Zhao P, Zhan Q, Wu G (2010) Eur J Cell Biol 89(6): 428-36
    › Primary publication · 20219263 (PubMed) · PMC2886128 (PubMed Central)